Nicola Beltraminelli | Chief Development Officer, Head of RED
INNATE PHARMA

Dr. Nicola Beltraminelli joined Innate Pharma as Vice President and Chief Development Officer in January 2022 and was recently appointed as Head of Reasearch Early Development of the organization. Dr. Beltraminelli brings 25 years of biotech experience to the role, and specifically in the development of biologic products from early discovery to GMP manufacture. 
In the past years, Dr. Beltraminelli served as Chief Technical Officer at Lysogene, he held senior level positions at HiFiBiO Therapeutics and served as CSO at BliNK Biomedical SAS.
Dr. Beltraminelli holds a PhD in Molecular Biology from the University of Lausanne, Switzerland, and currently serves as a Board member of MabDesign.